T A McDonagh
Affiliation: University of Glasgow
- Left ventricular dysfunction, natriuretic peptides, and mortality in an urban populationT A McDonagh
Department of Medical Cardiology, University of Glasgow, Royal Infirmary, 10 Alexandra Parade, Glasgow G31 2ER, UK
Heart 86:21-6. 2001....
- NT-proBNP and the diagnosis of heart failure: a pooled analysis of three European epidemiological studiesT A McDonagh
Department of Cardiology, Royal and Western Infirmaries, University of Glasgow, 10 Alexandra Parade, Glasgow, Scotland G31 2ER, UK
Eur J Heart Fail 6:269-73. 2004..An elevated NT-proBNP merely indicates the presence of 'cardio-renal distress' and should prompt referral for further investigation...
- Screening for left ventricular dysfunction: a step too far?T A McDonagh
Department of Medical Cardiology, University of Glasgow, Glasgow Royal Infirmary, 10 Alexandra Parade, Glasgow G31 2ER, UK
Heart 88:ii12-4. 2002
- ADEPT: Addition of the AT1 receptor antagonist eprosartan to ACE inhibitor therapy in chronic heart failure trial: hemodynamic and neurohormonal effectsD R Murdoch
Department of Cardiology, Western Infirmary, Glasgow, UK
Am Heart J 141:800-7. 2001..When added to ACE inhibitors, angiotensin II type 1 (AT1) antagonists may allow more complete blockade of the RAAS and preserve the beneficial effects of bradykinin accumulation not seen with AT1 receptor blockade alone...
- The prognostic use of right heart catheterization data in patients with advanced heart failure: how relevant are invasive procedures in the risk stratification of advanced heart failure in the era of neurohormones?R S Gardner
Department of Cardiology, University of Glasgow, Glasgow, UK
J Heart Lung Transplant 24:303-9. 2005..This study reconsiders the use of right heart catheterization data and compares their use to that of N-terminal pro-brain natriuretic peptide (NT-proBNP), a neurohormone linked with prognosis in chronic heart failure...
- N-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failureR S Gardner
The Scottish Cardiopulmonary Transplant Unit, Glasgow Royal Infirmary, Glasgow, UK
Eur Heart J 24:1735-43. 2003..The purpose of this study was to examine the prognostic ability of NT-proBNP in advanced heart failure and compare it to that of the LVEF, peak VO2 and the HFSS...
- Asymptomatic left ventricular dysfunction in the communityT A McDonagh
Department of Medical Cardiology, University of Glasgow Royal Infirmary, 10 Alexandra Parade, Glasgow, G31 6ER, Scotland t
Curr Cardiol Rep 2:470-4. 2000..As such it has the potential to be a cost-effective means of filtering subjects suspected of having LVD and allowing more appropriate use of tertiary referrals for specialist assessment and detailed echocardiography...
- Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapyD R Murdoch
Clinical Research Initiative in Heart Failure, West Medical Building, University of Glasgow, Scotland
Am Heart J 138:1126-32. 1999..We sought to determine whether titration of vasodilator therapy according to plasma brain natriuretic peptide (BNP) concentration may be of value in the individual optimization of vasodilator therapy in CHF...
- The prevalence of haemochromatosis gene mutations in the West of Scotland and their relation to ischaemic heart diseaseS Campbell
Department of Gastroenterology, Gartnavel General Hospital, Glasgow, UK
Heart 89:1023-6. 2003..This study aims to determine whether the two major mutations of the haemochromatosis (HFE) gene (C282Y and H63D) are associated with ischaemic heart disease (IHD) or myocardial infarction (MI)...
- Morphine for the relief of breathlessness in patients with chronic heart failure--a pilot studyM J Johnson
West of Scotland Rotation, Glasgow, UK
Eur J Heart Fail 4:753-6. 2002..Morphine has long been used to relieve symptoms in acute failure, but there is little evidence about this potentially useful palliative therapy in CHF...
- Validation of an echocardiographic wall motion index in heart failure due to ischaemic heart diseaseJ H McGowan
Department of Medical and Nuclear Cardiology, Glasgow Royal Infirmary, G31 2ER, Glasgow, UK
Eur J Heart Fail 3:731-7. 2001..This study aimed to examine the application of a wall motion index (WMI) method, using a nine-segment LV model in patients with chronic heart failure (CHF) due to IHD...
- Randomised controlled trial of continuous positive airway pressure and standard oxygen therapy in acute pulmonary oedema; effects on plasma brain natriuretic peptide concentrationsC A Kelly
Department of Respiratory Medicine, Royal Infirmary, Edinburgh, Scotland, UK
Eur Heart J 23:1379-86. 2002..The study aim was to compare the effects of continuous positive airway pressure (CPAP) on clinical outcomes and plasma neurohormonal concentrations in patients with acute pulmonary oedema...
- Lessons from the management of chronic heart failureT A McDonagh
Royal Brompton and Harefield NHS Trust, Sydney Street, London SW3 6NP, UK
Heart 91:ii24-7; discussion ii31, ii43-8. 2005..Applying such an approach to the care of the post-MI heart failure patient should be equally important...
- Importance of beta blockade in the treatment of advanced heart failureR S Gardner
Heart 89:1442-4. 2003
- The treatment of chronic heart failure due to left ventricular systolic dysfunctionR S Gardner
Department of Cardiology, Monklands Hospital, Airdrie
Clin Med 4:18-22. 2004
- N-terminal brain natriuretic peptide is predictive of death after cardiac transplantationR S Gardner
Heart 92:121-3. 2006